Skip to main navigation Skip to search Skip to main content

Dicentric (17;20)(p11.2;q11.2): an uncommon cytogenetic abnormality in myeloid malignancies

  • Carlos A. Tirado
  • , Aurelia M. Meloni-Ehrig
  • , Eian Wallenhorst
  • , Kristine Burks
  • , Jay Scheerle
  • , Maurice Morillon
  • , Jo Ann C. Kelly
  • , Deborah Heritage
  • , Alexander Spira
  • , Calvin D. Croft
  • , Lewis Glasser
  • , James N. Butera
  • , Philip Mowrey
  • Quest Diagnostics Incorporated
  • INOVA Fairfax Hospital
  • Brown University

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

We report on two patients with myeloid disorders and complex karyotypes including a dicentric chromosome, dic(17;20)(p11.2;q11.2), resulting in the loss of most of 17p and 20q. The presence of the centromeres of chromosomes 17 and 20 in the dic(17;20), as well as the loss of TP53, were confirmed by fluorescence in situ hybridization. Deletions of 17p and 20q are recurrent abnormalities in hematologic disorders, particularly myelodysplastic syndrome and acute myeloid leukemia). However, a dic(17;20) is an uncommon finding. According to the few reports in the literature, dic(17;20) is associated with an unfavorable prognosis. The key mechanism might be the loss of TP53 as well as other tumor suppressor genes in 20q that may have a critical role in tumor genesis.

Original languageEnglish
Pages (from-to)61-64
Number of pages4
JournalCancer Genetics and Cytogenetics
Volume170
Issue number1
DOIs
StatePublished - Oct 1 2006

Fingerprint

Dive into the research topics of 'Dicentric (17;20)(p11.2;q11.2): an uncommon cytogenetic abnormality in myeloid malignancies'. Together they form a unique fingerprint.

Cite this